HeartMate 3

Respects the blood

Building on the legacy of proven performance established by HeartMate II®, HeartMate 3 is designed to offer unprecedented blood-handling characteristics through the incorporation of Full MagLev™ flow technology.

Full MagLev flow technology allows the device’s rotor to be magnetically levitated, or suspended, by magnetic forces. The resulting contact-free environment is designed for hemocompatibility, with large, consistent blood-flow pathways designed to reduce blood shearing and hemolysis and to minimize complications.

Results from the HeartMate 3 CE Mark Clinical Trial may have significant implications for the care of patients with advanced heart failure:

  • No pump thrombosis, hemolysis, or pump malfunctions or exchanges 36
  • 98% 30-day survival and 92% 6-month survival (Excellent 30-day and 6-month survival)36
  • Significant improvement in NYHA class for 83% of patients36
  • Over a 100% improvement in 6-minute walk distance36
  • Progressive, sustained improvements in quality of life36

HeartMate 3 also offers:

  • A full range of operation, providing flow from 2.5 to 10 L/min to accommodate a broad range of clinical needs
  • Artificial pulsatility, designed to promote pump washing and minimize areas of stasis in the pump
  • Intrapericardial placement, for surgical ease and minimized complications
  • A thin, mechanical apical cuff lock, for quick and easy pump attachment
Important Safety Information

Intended use: HeartMate 3 is intended to provide hemodynamic support in patients with advanced, refractory left ventricular heart failure; either for short-term support, such as a bridge to cardiac transplantation (BTT) or myocardial recovery, or as long-term support, such as destination therapy (DT). HeartMate 3 is intended for use inside or outside the hospital.

Contraindications: HeartMate 3 is contraindicated in patients who cannot tolerate or are allergic to anticoagulation therapy.

Common side effects: Death, bleeding, cardiac arrhythmia, infection, respiratory failure, device malfunction, sepsis, right heart failure, renal failure, stroke, neurologic dysfunction, psychiatric episode, peripheral or device-related thromboembolic event, hemolysis, hepatic dysfunction, myocardial infarction.

Informatii suplimentare:

Brosura de prezentare (Eng)
Site producator: St. Jude Medical

HeartMate-Php-Sante-International